Evolent Health Inc Cash Flow Reinvestment Rate

Latest as of December 2025: 0.16x

Evolent Health Inc cash flow reinvestment rate. Evolent Health Inc (EVH) has a Cash Flow Reinvestment Rate of 0.16x as of December 2025, reinvesting $7.76 Million (capex $7.76 Million ) from operating cash flow of $48.80 Million. Explore EVH operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.16x
(Capex + Investments) / Operating CF

Total Reinvested

$7.76 Million
Capex + Investments

Operating Cash Flow

$48.80 Million
USD

Capital Expenditures

$7.76 Million
USD

Cash Flow Reinvestment Rate of Evolent Health Inc (2021–2025)

Cash flow reinvestment rate of Evolent Health Inc from 2021 to 2025. Historical reinvestment intensity for Evolent Health Inc across 4 annual periods. Explore Evolent Health Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Evolent Health Inc Cash Flow Reinvestment Rate by Year (2021–2025)

Evolent Health Inc cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for Evolent Health Inc. For the full cash flow conversion analysis, see Evolent Health Inc (EVH) cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.88x $34.09 Million $38.84 Million $34.09 Million ▼ -81.2%
2024 4.68x $87.83 Million $18.77 Million $24.89 Million ▲ +50.7%
2023 3.10x $442.69 Million $142.58 Million $28.75 Million ▲ +51.9%
2021 2.04x $79.20 Million $38.75 Million $24.98 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow